You are subscribed to the Dermatology Times eNews.
eNewsletter Subscribe
Print/Digital Edition Subscribe
May 11, 2015
Web Version | Digital Edition | Share with a colleague
Like Tweet
THIS MONTH IN SKIN CANCER
Surrogate measures test efficacy of agents. » Clues
Short ALA incubation with blue light therapy yields dramatic results. » Study results
Identifying specific neo-antigens in melanoma is no easy task. » Learn more on the different approach.
ADVERTISEMENT
Botulinum toxin updates and innovations Learn more about the latest in clinical research and techniques for wrinkle treatment and facial enhancement with botulinum toxin.
RECOMMENDED ARTICLES
• Can sun damage cause genetic change?
• GEP + Sentinal Lymph biopsy = accurate predictor of metastasis?
• New GEP test predicts metastatic risk
New Job Opportunities
CA - Integrated Dermatology
CA - MedDerm Associates
CA - UC Irvine Health Dept Of Dermatology
CO - Integrated Dermatology
CT - Integrated Dermatology
District of Columbia-Integrated Dermatology
FL - Integrated Dermatology
HI - Sleep Center Hawaii
IL - Integrated Dermatology
MA - Brigham and Women's Hospital
MA - Integrated Dermatology
National - Leavitt Management Group
National - Integrated Dermatology
NC - Integrated Dermatology
NM - Integrated Dermatology
NY - Company Confidential
NY - Juva Skin & Laser Center
OK - Tulsa Cancer Institute
OR - Cynthia Dreyer, MD
TX - Company Confidential
UT - Integrated Dermatology
VA - Integrated Dermatology
WI - Gundersen Lutheran Health System
Editorial Questions? Contact the Editorial Team. Click Here. Sales, Reprints, Classified questions? Contact the Sales Team. Click Here.
UBM MEDICA
Like
Tweet
